JRS (JRS) Stock Price & Analysis
JRS (JRS) rose 0.93% to USD 8.69 as of July 25, 2026 at 02:21 UTC, according to Nexqual real-time market data.
JRS last closed at USD 8.61; the session ranged USD 8.62–8.7 on volume of 122,622 shares. Market capitalization is —, with a 52-week range of USD 7.12–8.75 (NYQ). Source: Nexqual, July 25, 2026 at 02:21 UTC.
Key Statistics (as of July 25, 2026 at 02:21 UTC)
| Price | USD 8.69 |
|---|---|
| Change | ▲ 0.93% (up) |
| Previous Close | USD 8.61 |
| Open | USD 8.65 |
| Day Range | USD 8.62 – 8.7 |
| 52-Week Range | USD 7.12 – 8.75 |
| Volume | 122,622 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (JRS)
Nexqual's technical model rates JRS "BUY" based on 5 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 02:21 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 60.71 (neutral) |
| vs SMA50 | Above (USD 8.37) |
| MACD | 0.09 (positive) |
Analyst Ratings (JRS)
Wall Street analysts rate JRS "None", per Nexqual as of July 25, 2026 at 02:21 UTC.
| Consensus Rating | None |
|---|
Earnings (JRS)
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financials & Fundamentals (JRS)
| Total Revenue | $13.63M |
|---|---|
| Revenue Growth (YoY) | +28.10% |
| Gross Margin | +100.00% |
| Operating Margin | +74.44% |
| Profit Margin | -31.64% |
| ROE | -1.73% |
| Debt / Equity | 45.11 |
| Current Ratio | 0.07 |
| Total Debt | $107.02M |
| Free Cash Flow | $-3.71M |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financial Health Score (JRS)
Nexqual rates JRS's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 02:21 UTC.
| Growth | Strong — Revenue +28% YoY (latest Q) |
|---|---|
| Profitability | Weak — Small revenue base — building scale |
| Balance Sheet | Mixed — Debt/Equity 0.5x |
| Cash Flow | Weak — FCF negative: -$4M, burning cash |
| Efficiency | Critical — ROE -2%, ROA 1.8% |
Ownership (JRS)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +24.16% |
| Short % of Float | +0.17% |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Major Backers & Investors (JRS)
Notable institutional backers of JRS include Morgan Stanley, Advisors Asset Management, Inc., Baird Financial Group, Inc., according to Nexqual as of July 25, 2026 at 02:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 5.8% |
| Advisors Asset Management, Inc. | 2.28% |
| Baird Financial Group, Inc. | 2.16% |
| Kanen Wealth Management LLC | 1.83% |
| Pathstone Holdings, LLC | 1.45% |
| Private Advisor Group, LLC | 1.38% |
| World Funds Trust-Philotimo Focused Growth & Income Fund | 1.1% |
| LPL Financial LLC | 0.75% |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NRO | 70968 | USD 3.06 | ▲ 1.32% |
| JQC | Nuveen Credit Strategies Income | USD 4.75 | ▼ 0.84% |
| RFI | Cohen & Steers Total Return Rea | USD 11.7 | ▲ 2.54% |
| IGR | CBRE Clarion Global Real Estate | USD 4.7 | ▲ 0.86% |
| JRI | Nuveen Real Asset Income and Gr | USD 13.06 | ▲ 1.08% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:21 UTC. This page is informational and not investment advice.